CD86 regulates IgG1 production via a CD19-dependent mechanism

Journal of Immunology

Volumn 179, Issue 3, 2007, Pages 1516-1523

  Kin, Nicholas W ^a   Sanders, Virginia M ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b 2194 Graves Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD28 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; HEMOCYANIN; IMMUNOGLOBULIN G1; INTERLEUKIN 4; OCTAMER TRANSCRIPTION FACTOR 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE LYN; RAG2 PROTEIN; VAV PROTEIN; IMMUNOGLOBULIN G; MESSENGER RNA; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEMALE; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ADOPTIVE TRANSFER; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DOWN REGULATION; ENZYMOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD19; ANTIGENS, CD86; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; FEMALE; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OCTAMER TRANSCRIPTION FACTOR-2; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 34548611610     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.3.1516     Document Type: Article

References (52)

1. Freeman, G. J., A. S. Freedman, J. M. Segil, G. Lee, J. F. Whitman, and L. M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143: 2714-2722.
2. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. A. Restivo, Jr., L. A. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262: 909-911.
3. Azuma, M., D. Ito, K. Okumara, J. H. Phillips, L. L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366: 76-79.
4. Roy, M., A. Aruffo, J. Ledbetter, P. Linsley, M. Kehry, and R. Noelle. 1995. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25: 596-603.
5. Stack, R. M., D. J. Lenschow, G. S. Gray, J. A. Bluestone, and F. W. Fitch. 1994. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J. Immunol. 152: 5723-5733.
6. Hathcock, K. S., G. Laszlo, H. B. Dickler, J. Bradshaw, P. Linsley, and R. J. Hodes. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262: 905-907.
7. Lenschow, D. J., G. H. T. Su, L. A. Zuckerman, N. Nabavi, C. L. Jellis, G. S. Gray, J. Miller, and J. A. Bluestone. 1993. Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. USA 90: 11054-11058.
8. Kasprowicz, D. J., A. P. Kohm, M. T. Berton, A. J. Chruscinski, A. Sharpe, and V. M. Sanders. 2000. Stimulation of the B cell receptor, CD86 (B7-2), and the β 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell. J. Immunol. 165: 680-690.
9. Kohm, A. P., A. Mozaffarian, and V. M. Sanders. 2002. B cell receptor- and β-2-adrenergic receptor-induced regulation of B7-2 (CD86) expression in B cells. J. Immunol. 168: 6314-6322.
10. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Ann. Rev. Immunol. 11: 191-212.
11. 1 is explained by differential induction of NF-κB/Rel proteins. Mol. Cell. Biol. 18: 5523-5532.
12. Warren, W. D., K. L. Roberts, L. A. Linehan, and M. T. Berton. 1999. Regulation of the germline immunoglobulin Cγ1 promoter by CD40 ligand and IL-4: dual role for tandem NF-κB binding sites. Mol. Immunol. 36: 31-44.
13. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261: 609-612.
14. Borriello, F., M. P. Sethna, S. D. Boyd, A. N. Schweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson, G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6: 303-313.
15. Podojil, J. R., N. W. Kin, and V. M. Sanders. 2004. CD86 and β2-adrenergic receptor signaling pathways, respectively, increase Oct-2 and OCA-B expression and binding to the 3′-IgH enhancer in B cells. J. Biol. Chem. 279: 23394-23404.
16. Podojil, J. R., and V. M. Sanders. 2003. Selective regulation of mature IgG1 transcription by CD86 and β2-adrenergic receptor stimulation. J. Immunol. 170: 5143-5151.
17. Jeannin, P., Y. Delneste, S. Lecoanet-Henchoz, J.-F. Gauchat, J. Ellis, and J.-Y. Bonnefoy. 1997. CD86 (B7-2) on human B cells: a functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells. J. Biol. Chem. 272: 15613-15619.
18. Suvas, S., V. Singh, S. Sahdev, H. Vohra, and J. A. Agrewala. 2002. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J. Biol. Chem. 277: 7766-7775.
19. Sahoo, N. C., K. V. Rao, and K. Natarajan. 2002. CD80 expression is induced on activated B cells following stimulation by CD86. Scand. J. Immunol. 55: 577-584.
20. Kin, N. W., and V. M. Sanders. 2006. CD86 stimulation on a B cell activates the phosphatidylinositol 3-kinase/Akt and phospholipase Cγ2/protein kinase Cαβ signaling pathways. J. Immunol. 176: 6727-6735.
21. Baban, B., A. M. Hansen, P. R. Chandler, A. Manlapat, A. Bingaman, D. J. Kahler, D. H. Munn, and A. L. Mellor. 2005. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. Int. Immunol. 17: 909-919.
22. Orabona, C., U. Grohmann, M. L. Belladonna, F. Fallarino, C. Vacca, R. Bianchi, S. Bozza, C. Volpi, B. L. Salomon, M. C. Fioretti, et al. 2004. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat. Immunol. 5: 1134-1142.
23. Del Nagro, C. J., D. C. Otero, A. N. Anzelon, S. A. Omori, R. V. Kolla, and R. C. Rickert. 2005. CD19 function in central and peripheral B-cell development. Immunol. Res. 31: 119-131.
24. Engel, P., L. J. Zhou, D. C. Ord, S. Sato, B. Koller, and T. F. Tedder. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3: 39-50.
25. Rickert, R. C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376: 352-355.
26. Matsumoto, A. K., J. Kopicky-Burd, R. H. Carter, D. A. Tuveson, T. F. Tedder, and D. T. Fearon. 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173: 55-64.
27. Bradbury, L. E., G. S. Kansas, S. Levy, R. L. Evans, and T. F. Tedder. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149: 2841-2850.
28. Carter, R. H., and D. T. Fearon. 1992. Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256: 105-107.
29. Yazawa, N., M. Fujimoto, S. Sato, K. Miyake, N. Asano, Y. Nagai, O. Takeuchi, K. Takeda, H. Okochi, S. Akira, et al. 2003. CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes. Blood 102: 1374-1380.
30. Bobbitt, K. R., and L. B. Justement. 2000. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22. J. Immunol. 165: 5588-5596.
31. Fujimoto, M., J. C. Poe, P. J. Jansen, S. Sato, and T. F. Tedder. 1999. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J. Immunol. 162: 7088-7094.
32. Xu, Y., K. W. Harder, N. D. Huntington, M. L. Hibbs, and D. M. Tarlinton. 2005. Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 22: 9-18.
33. Lumsden, J. M., J. A. Williams, and R. J. Hodes. 2003. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo. J. Immunol. 170: 781-787.
34. Wang, Y., S. R. Brooks, X. Li, A. N. Anzelon, R. C. Rickert, and R. H. Carter. 2002. The physiologic role of CD19 cytoplasmic tyrosines. Immunity 17: 501-514.
35. Gardby, E., X. J. Chen, and N. Y. Lycke. 2001. Impaired CD40-signalling in CD19-deficient mice selectively affects Th2-dependent isotype switching. Scand. J. Immunol. 53: 13-23.
36. Sato, S., A. S. Miller, M. C. Howard, and T. F. Tedder. 1997. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J. Immunol. 159: 3278-3287.
37. Baccam, M., and G. A. Bishop. 1999. Membrane-bound CD154, but not CD40-specific antibody, mediates NF-κB-independent IL-6 production in B cells. Eur. J. Immunol. 29: 3855-3866.
38. Pongratz, G., J. W. McAlees, D. H. Conrad, R. S. Erbe, K. M. Haas, and V. M. Sanders. 2006. The level of IgE produced by a B cell is regulated by norepinephrine in a p38 MAPK- and CD23-dependent manner. J. Immunol. 177: 2926-2938.
39. 2+ mobilization. J. Exp. Med. 186: 1897-1910.
40. Tuveson, D. A., R. H. Carter, S. P. Soltoff, and D. T. Fearon. 1993. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260: 986-989.
41. Matsumoto, A. K., D. R. Martin, R. H. Carter, L. B. Klickstein, J. M. Ahearn, and D. T. Fearon. 1993. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J. Exp. Med. 178: 1407-1417.
42. Petrie, R. J., P. P. Schnetkamp, K. D. Patel, M. Awasthi-Kalia, and J. P. Deans. 2000. Transient translocation of the B cell receptor and Src homology 2 domain-containing inositol phosphatase to lipid rafts: evidence toward a role in calcium regulation. J. Immunol. 165: 1220-1227.
43. Cherukuri, A., P. C. Cheng, H. W. Sohn, and S. K. Pierce. 2001. The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity 14: 169-179.
44. Pierce, S. K. 2002. Lipid rafts and B-cell activation. Nat. Rev. Immunol. 2: 96-105.
45. Meyer zum Bueschenfelde, C. O., J. Unternaehrer, I. Mellman, and K. Bottomly. 2004. Regulated recruitment of MHC class II and costimulatory molecules to lipid rafts in dendritic cells. J. Immunol. 173: 6119-6124.
46. Freeman, G. J., F. Borriello, R. J. Hodes, H. Reiser, J. G. Gribben, J. W. Ng, J. Kim, J. M. Goldberg, K. Hathcock, G. Laszlo, et al. 1993. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178: 2185-2192.
47. Zhang, X., J. C. Schwartz, S. C. Almo, and S. G. Nathenson. 2003. Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling. Proc. Natl. Acad. Sci. USA 100: 2586-2591.
48. Bhatia, S., M. Edidin, S. C. Almo, and S. G. Nathenson. 2005. Different cell surface oligomeric states of B7-1 and B7-2: implications for signaling. Proc. Natl. Acad. Sci. USA 102: 15569-15574.
49. Razi-Wolf, Z., G. J. Freeman, F. Galvin, B. Benacerraf, and L. M. Nadler. 1992. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. USA 89: 4214-4210.
50. Delneste, Y., R. Bosotti, G. Magistrelli, J. Y. Bonnefoy, and J. F. Gauchat. 2000. Detection of a polymorphism in exon 8 of the human CD86 gene. Immunogenetics 51: 762-763.
51. Marin, L. A., M. R. Moya-Quiles, M. Miras, M. Muro, A. Minguela, J. Bermejo, P. Ramirez, A. M. Garcia-Alonso, P. Parrilla, and M. R. Alvarez-Lopez. 2005. Evaluation of CD86 gene polymorphism at +1057 position in liver transplant recipients. Transplant Immunol. 15: 69-74.
52. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Ann. Rev. Immunol. 14: 233-258.